My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 531

    1.

    Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.

    Saukkonen T, Shojaee-Moradie F, Williams RM, Amin R, Yuen KC, Watts A, Acerini CL, Umpleby AM, Dunger DB.

    Diabetes. 2006 Aug;55(8):2365-70.PMID: 16873702 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.

    Saukkonen T, Amin R, Williams RM, Fox C, Yuen KC, White MA, Umpleby AM, Acerini CL, Dunger DB.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4634-41.PMID: 15356074 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.

    Acerini CL, Harris DA, Matyka KA, Watts AP, Umpleby AM, Russell-Jones DL, Dunger DB.

    Metabolism. 1998 Dec;47(12):1481-9.PMID: 9867078 [PubMed - indexed for MEDLINE]Related articles

    4.

    Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.

    Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sönksen PH, Dunger DB, Umpleby AM.

    J Clin Endocrinol Metab. 2004 Jan;89(1):425-32.PMID: 14715881 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.

    Carroll PV, Umpleby M, Alexander EL, Egel VA, Callison KV, Sönksen PH, Russell-Jones DL.

    Clin Endocrinol (Oxf). 1998 Dec;49(6):739-46.PMID: 10209561 [PubMed - indexed for MEDLINE]Related articles

    6.

    Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus.

    Crowne EC, Samra JS, Cheetham T, Watts A, Holly JM, Dunger DB.

    Metabolism. 1998 Jan;47(1):31-8.PMID: 9440474 [PubMed - indexed for MEDLINE]Related articles

    7.

    The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.

    Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J.

    J Clin Endocrinol Metab. 2000 Apr;85(4):1518-24.PMID: 10770191 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus.

    Crowne EC, Samra JS, Cheetham T, Acerini CL, Watts A, Holly JM, Dunger DB.

    J Clin Endocrinol Metab. 2001 Aug;86(8):3686-91.PMID: 11502796 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.

    Clemmons DR, Sleevi M, Allan G, Sommer A.

    J Clin Endocrinol Metab. 2007 Jul;92(7):2652-8. Epub 2007 Apr 10.PMID: 17426090 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.

    Clemmons DR, Moses AC, Sommer A, Jacobson W, Rogol AD, Sleevi MR, Allan G.

    Growth Horm IGF Res. 2005 Aug;15(4):265-74.PMID: 16005252 [PubMed - indexed for MEDLINE]Related articles

    11.

    Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.

    Williams RM, Yuen K, White D, Mallard B, Dalton RN, Acerini CL, Dunger DB.

    Clin Endocrinol (Oxf). 2006 Oct;65(4):439-45.PMID: 16984235 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effects of recombinant human insulin-like growth factor-I (IGF-I) administration on the levels of IGF-I, IGF-II and IGF-binding proteins in adolescents with insulin-dependent diabetes mellitus.

    Cheetham TD, Taylor A, Holly JM, Clayton K, Cwyfan-Hughes S, Dunger DB.

    J Endocrinol. 1994 Aug;142(2):367-74.PMID: 7523562 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus.

    Cheetham TD, Holly JM, Baxter RC, Meadows K, Jones J, Taylor AM, Dunger DB.

    J Endocrinol. 1998 Apr;157(1):81-7.PMID: 9614361 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.

    Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.

    Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1360-8.PMID: 12006367 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.

    Böni-Schnetzler M, Hauri C, Zapf J.

    Diabetologia. 1999 Feb;42(2):160-6.PMID: 10064095 [PubMed - indexed for MEDLINE]Related articles

    16.

    Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.

    Boonen S, Rosen C, Bouillon R, Sommer A, McKay M, Rosen D, Adams S, Broos P, Lenaerts J, Raus J, Vanderschueren D, Geusens P.

    J Clin Endocrinol Metab. 2002 Apr;87(4):1593-9.PMID: 11932288 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.

    Lieberman SA, Bukar J, Chen SA, Celniker AC, Compton PG, Cook J, Albu J, Perlman AJ, Hoffman AR.

    J Clin Endocrinol Metab. 1992 Jul;75(1):30-6.PMID: 1377706 [PubMed - indexed for MEDLINE]Related articles

    18.

    Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment.

    Halldin MU, Brismar K, Tuvemo T, Gustafsson J.

    Clin Endocrinol (Oxf). 2002 Dec;57(6):735-43.PMID: 12460323 [PubMed - indexed for MEDLINE]Related articles

    19.

    Short-term hypocaloric nutrition but not bed rest decrease insulin sensitivity and IGF-I bioavailability in healthy subjects: the importance of glucagon.

    Nygren J, Thorell A, Brismar K, Karpe F, Ljungqvist O.

    Nutrition. 1997 Nov-Dec;13(11-12):945-51.PMID: 9433709 [PubMed - indexed for MEDLINE]Related articles

    20.

    Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.

    Thrailkill K, Quattrin T, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Kotlovker D, Giltinan D, Gesundheit N, Martha P Jr.

    J Clin Endocrinol Metab. 1997 Apr;82(4):1181-7.PMID: 9100593 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity